NEW YORK, Oct. 8 - When Hewlett-Packard spun off Agilent Technologies in 1999, it appeared that its interest in the life sciences went with it. But David Valenta, HP’s global marketing development manager for life sciences, told GenomeWeb that the company is a solid contender in the life-sciences computing market.

Despite HP’s relatively late entry into the sector and stiff competition from Sun, IBM, and Compaq, Valenta remains confident that the company’s strategy of partnering with software and solution providers will give it an edge in the market. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.